Search research articles
Contact Us
Filters
Showing results (31-40 of 81) with videos related to
Page
of 9
Sort By:
Journal of Virology
|
November 1, 1992
In vitro enzymatic activity of human immunodeficiency virus type 1 reverse transcriptase mutants in the highly conserved YMDD amino acid motif correlates with the infectious potential of the proviral genome
J K Wakefield, S A Jablonski, C D Morrow
Journal of Virology
|
March 1, 1995
Encapsidation of poliovirus replicons encoding the complete human immunodeficiency virus type 1 gag gene by using a complementation system which provides the P1 capsid protein in trans
D C Porter, D C Ansardi, C D Morrow
Journal of Virology
|
May 1, 1984
ATP is required for initiation of poliovirus RNA synthesis in vitro: demonstration of tyrosine-phosphate linkage between in vitro-synthesized RNA and genome-linked protein
C D Morrow, J Hocko, M Navab, et al.
Journal of Virology
|
June 1, 1991
Expression of human immunodeficiency virus type 1 (HIV-1) gag, pol, and env proteins from chimeric HIV-1-poliovirus minireplicons
W S Choi, R Pal-Ghosh, C D Morrow
Methods in Molecular Medicine
|
February 5, 2014
Methods for the use of poliovirus vectors for gene delivery
C D Morrow, D C Ansardi, D C Porter
Journal of Clinical Immunology
|
October 1, 1982
Human IgA antibody and immunoglobulin production after in vivo tetanus toxoid immunization: size and surface membrane phenotype analysis
C J Thiele, C D Morrow, R H Stevens
Journal of Virology
|
July 1, 1992
Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles
D C Ansardi, D C Porter, C D Morrow
Journal of Neurovirology
|
May 24, 2000
Targeted foreign gene expression in spinal cord neurons using poliovirus replicons
A W Bledsoe, G Y Gillespie, C D Morrow
Journal of Virology
|
October 1, 1995
Human immunodeficiency virus type 1 can use different tRNAs as primers for reverse transcription but selectively maintains a primer binding site complementary to tRNA(3Lys)
J K Wakefield, A G Wolf, C D Morrow
Journal of Virology
|
February 1, 1996
Construction of a type 1 human immunodeficiency virus that maintains a primer binding site complementary to tRNA(His)
J K Wakefield, S M Kang, C D Morrow
Page
of 9
Search research articles
Search
Showing results (31-40 of 81) with videos related to
Sort By:
Page
of 9
Journal of Virology
|
November 1, 1992
In vitro enzymatic activity of human immunodeficiency virus type 1 reverse transcriptase mutants in the highly conserved YMDD amino acid motif correlates with the infectious potential of the proviral genome
J K Wakefield, S A Jablonski, C D Morrow
Journal of Virology
|
March 1, 1995
Encapsidation of poliovirus replicons encoding the complete human immunodeficiency virus type 1 gag gene by using a complementation system which provides the P1 capsid protein in trans
D C Porter, D C Ansardi, C D Morrow
Journal of Virology
|
May 1, 1984
ATP is required for initiation of poliovirus RNA synthesis in vitro: demonstration of tyrosine-phosphate linkage between in vitro-synthesized RNA and genome-linked protein
C D Morrow, J Hocko, M Navab, et al.
Journal of Virology
|
June 1, 1991
Expression of human immunodeficiency virus type 1 (HIV-1) gag, pol, and env proteins from chimeric HIV-1-poliovirus minireplicons
W S Choi, R Pal-Ghosh, C D Morrow
Methods in Molecular Medicine
|
February 5, 2014
Methods for the use of poliovirus vectors for gene delivery
C D Morrow, D C Ansardi, D C Porter
Journal of Clinical Immunology
|
October 1, 1982
Human IgA antibody and immunoglobulin production after in vivo tetanus toxoid immunization: size and surface membrane phenotype analysis
C J Thiele, C D Morrow, R H Stevens
Journal of Virology
|
July 1, 1992
Myristylation of poliovirus capsid precursor P1 is required for assembly of subviral particles
D C Ansardi, D C Porter, C D Morrow
Journal of Neurovirology
|
May 24, 2000
Targeted foreign gene expression in spinal cord neurons using poliovirus replicons
A W Bledsoe, G Y Gillespie, C D Morrow
Journal of Virology
|
October 1, 1995
Human immunodeficiency virus type 1 can use different tRNAs as primers for reverse transcription but selectively maintains a primer binding site complementary to tRNA(3Lys)
J K Wakefield, A G Wolf, C D Morrow
Journal of Virology
|
February 1, 1996
Construction of a type 1 human immunodeficiency virus that maintains a primer binding site complementary to tRNA(His)
J K Wakefield, S M Kang, C D Morrow
Page
of 9